NovoArc Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Grant
- Investors
-
4
NovoArc General Information
Description
Developer of specialized lipid-based components designed for use in drug formulation and delivery applications. The company utilizes a proprietary technology platform to produce highly pure, semi-synthetic tetraether lipids inspired by extremophilic microorganisms, enabling pharmaceutical developers to improve the protection, delivery efficiency and overall effectiveness of active pharmaceutical ingredients.
Contact Information
Website
www.novoarc.atCorporate Office
- Pottendorfer Straße 23-25, 4, 4-1
- Vienna, 1120
- Austria
Corporate Office
- Pottendorfer Straße 23-25, 4, 4-1
- Vienna, 1120
- Austria
NovoArc Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Grant | 01-Jan-2022 | Completed | Generating Revenue | |||
| 5. Angel (individual) | Completed | Generating Revenue | ||||
| 4. Grant | Completed | Generating Revenue | ||||
| 3. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2019 | Completed | Generating Revenue | |||
| 1. University Spin-Out | Completed | Generating Revenue |
NovoArc Patents
NovoArc Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024330157-A1 | Lipid nanoparticle with nucleic acid cargo and ionizable lipid | Pending | 01-Sep-2023 | ||
| EP-4770622-A1 | Lipid nanoparticle with nucleic acid cargo and ionizable lipid | Pending | 01-Sep-2023 | ||
| WO-2025046121-A1 | Lipid nanoparticle with nucleic acid cargo and ionizable lipid | Inactive | 01-Sep-2023 | ||
| AU-2023347022-A1 | Lipid nanoparticle with nucleic acid cargo | Pending | 21-Sep-2022 | ||
| EP-4342460-A1 | Lipid nanoparticle with nucleic acid cargo | Inactive | 21-Sep-2022 | A61K9/5123 |
NovoArc Signals
NovoArc Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Austria Wirtschaftsservice | Venture Capital | Minority | ||
| Österreichische Forschungsförderungsgesellschaft | Government | |||
| TU Wien Innovation Incubation Center | Accelerator/Incubator | Minority | ||
| TU Wien | University |
NovoArc FAQs
-
When was NovoArc founded?
NovoArc was founded in 2021.
-
Where is NovoArc headquartered?
NovoArc is headquartered in Vienna, Austria.
-
What is the size of NovoArc?
NovoArc has 17 total employees.
-
What industry is NovoArc in?
NovoArc’s primary industry is Drug Delivery.
-
Is NovoArc a private or public company?
NovoArc is a Private company.
-
What is NovoArc’s current revenue?
The current revenue for NovoArc is .
-
Who are NovoArc’s investors?
Austria Wirtschaftsservice, Österreichische Forschungsförderungsgesellschaft, TU Wien Innovation Incubation Center, and TU Wien have invested in NovoArc.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process